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Neuroblast proliferationEpigenetic mechanisms are fundamental for shaping the activity of the central nervous system (CNS). Methyl-
CpG binding protein 2 (MECP2) acts as a bridge between methylated DNA and transcriptional effectors respon-
sible for differentiation programs in neurons. The importance of MECP2 dosage in CNS is evident in Rett Syn-
drome and MECP2 duplication syndrome, which are neurodevelopmental diseases caused by loss-of-function
mutations or duplication of the MECP2 gene, respectively. Although many studies have been performed on
Rett syndromemodels, little is known about the effects of an increase inMECP2 dosage. Herein, we demonstrate
thatMECP2 overexpression affects neural tube formation, leading to a decrease in neuroblast proliferation in the
neural tube ventricular zone. Furthermore, an increase inMECP2doseprovokes premature differentiation of neu-
ral precursors accompanied by greater cell death, resulting in a loss of neuronal populations. Overall, our data in-
dicate that correct MECP2 expression levels are required for proper nervous system development.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Introduction
During development, mitotically active precursors located in the
neuroepithelium give rise to specialized neuronal and glial cells that de-
ﬁne the adult nervous system. To maintain the brain's complexity, neu-
rons originating from the neural tube undergo mitotic quiescence.
Therefore, neuronal differentiation encompasses an elaborate develop-
mental program in which neurogenic and antiproliferative signals
work together to guarantee the differentiated state. This developmental
step is mediated by genetic and epigenetic factors. Among the latter,
chromatin remodelers (Clapier and Cairns, 2009), histone variants
(Kamakaka and Biggins, 2005), histone post-translational modiﬁcations
(Kouzarides, 2007) and DNA methylation (Miranda and Jones, 2007)
are strongly involved in regulating the proliferation and differentiation
of neural precursor cells. The importance of this regulation is highlight-
ed by several neurological disorders caused by mutations in epigenetic
genes, such as Rett syndrome (RTT), alpha thalassemia/mental retarda-
tion X-linked syndrome, Rubinstein–Taybi syndrome and Cofﬁn–Lowry
syndrome (Urdinguio et al., 2009).and Biology Program (PEBC),
8908 L'Hospitalet, Barcelona,
steller@idibell.cat (M. Esteller).
ect.com).
. This is an open access article underAmong the epigenetic regulators of the brain, methyl-CpG-binding
proteins are responsible for reading the methylation code of DNA and
therefore, for regulating gene transcription (Klose and Bird, 2006). In fact,
a mutation in the best-known protein of this family, MECP2 (methyl-CpG
binding protein 2), is responsible for RTT (Amir et al., 1999). MECP2 is a
basic nuclear protein that acts mainly as a transcriptional repressor,
preferentially binding to methylated DNA sequences (Klose et al., 2005;
Lewis et al., 1992). Although MECP2 is widely expressed, MECP2 levels
are highest in the brain, principally in mature postmigratory neurons
(Jung et al., 2003). MECP2 protein levels are low during embryogenesis
and increase progressively during the postnatal period of neuronalmatura-
tion (Balmer et al., 2003; Cohenet al., 2003). In addition to its necessary role
in mature neuronal and glial cells, MECP2 has been implicated in neuronal
speciﬁcation during early embryogenesis in several species (Coverdale
et al., 2004; Stancheva et al., 2003). Moreover, MECP2 has been shown to
promote neuronal differentiation of neural stem cells while repressing
astrocyte differentiation (Tsujimura et al., 2009).
The striking ﬁnding that MECP2 nucleotide mutations or duplica-
tions cause Rett syndrome or MECP2 duplication syndrome, respective-
ly, suggests that careful regulation of this gene is necessary for correct
brain development and function, as both overexpression and reduced
expression are associated with neurodevelopmental disorders (Collins
et al., 2004; del Gaudio et al., 2006). Intriguingly, a loss of MECP2
function and an increase inMECP2 dosage lead to clinically similar neu-
rological disorders (Van Esch et al., 2005). However, although many
studies have been performed on MECP2 loss-of-function models, littlethe CC BY license (http://creativecommons.org/licenses/by/3.0/).
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in either the adult or developing brain.
Using a well-known developmental model, the chick embryo neural
tube, we sought to investigate the effects of humanMECP2 overexpres-
sion on the proliferating progenitor cells of neurons and glia. Here, we
show that MECP2 dosage is fundamental for proper neural tube devel-
opment and demonstrate that MECP2 overexpression provokes prema-
ture differentiation of proliferating progenitor cells. This ectopic
differentiation leads to cell-cycle exit and cell death, ultimately
resulting in decreased neuronal populations.
Materials and methods
Plasmids
The human MECP2_e1 full-length coding sequence was cloned into
pCIG vector (Megason and McMahon, 2002). The vector comprises
CMV enhancer and beta-actin promoter, followed by multiple cloning
sites, internal ribosomal entry site (IRES) and a nuclear-localized
green ﬂuorescent protein (GFP).
Antibodies
The following primary antibodies were used: anti-MECP2
(Diagenode, custom); anti-BrdU (DSHB, G3G4); anti-phosphoH3S10
(Millipore, 05–806); anti-neural β-tubulin III (Tuj1) (R&D systems,
MAB1195); anti HuC/D (Life Technologies, A-21271); anti-N-cadherin
(R&D systems, AF6426); anti-active Caspase 3 (BD pharmingen,
559565); anti-active Caspase 8 (Millipore, MAB10754) and anti-β-
actin-peroxidase (Sigma, A3854)
Chick in ovo electroporation
Eggs fromWhite-Leghorn chickens were incubated at 38.5 °C and
70% humidity. Embryos were staged according to Hamburger and
Hamilton (HH) (Hamburger and Hamilton, 1992). Chick embryos
were electroporated with puriﬁed plasmid DNA at 2–3 μg/μl in H2O
with 50 ng/ml of Fast Green. Plasmid DNA was injected into the
lumen of HH10 neural tubes, electrodes were placed at both sides
of the neural tube and ﬁnally, the embryos were electroporated by
an IntracelDual Pulse (TSS-100) delivering ﬁve 50 ms square pulses
of 20–25 V.
mRNA extraction and RT-PCR
RNAwas extractedwith a Trizol reagent (Invitrogen) from dissected
neural tubes according to the manufacturer's protocol. Single-stranded
cDNA was synthesized with Thermoscript reverse-transcriptase and
random hexamers (Life Technologies), and then subjected to PCR with
the following primers: cMECP2, forward 5′-GGACCAGGAAGCTCAAAC
AGC-3′ and reverse 5′-TTGGGGCTCTTGGCTTTCTTG-3′; Gapdh, forward
5′-CTGAATGGGAAGCTTACTG-3′ and reverse, 5′-CATCATACTTGGCTGG
TTTC-3′.
Western blotting
Neural tubeswere dissected from several embryos at the same stage,
pooled together and total protein was extracted with a Laemmli buffer.
Equal amounts of protein (20 μg) were boiled for 10 min and β-
mercaptoethanol was added to a 3% ﬁnal concentration. Samples were
then separated by electrophoresis on 10% SDS-PAGE gels, and trans-
ferred to nitrocellulose membranes. Membranes were blocked in 5%
skim milk powder in PBS plus 0,1% Tween 20 for 1 h at room tempera-
ture and then incubated overnight at 4 °C with primary antibodies. For
MECP2 (1:2000) antibody, an anti-rabbit HRP-conjugated secondaryantibody (1:10,000) was used. Finally, complexes on the membrane
were visualized using an ECL detection kit (GEHealthcare Life Sciences).
BrdU incorporation
Bromodeoxyuridine (BrdU, 0.5 μg/μl) was injected into the chick
embryo neural tube lumen 30 min before ﬁxation. Before anti-BrdU an-
tibody incubation (which was performed as described below), the sec-
tions were treated with HCl 2 N for 30 min and washed with NaBorate
0.1 M (pH 8.5).
Indirect immunoﬂuorescence
The collected brachial regions from embryos were ﬁxed for 2 h at 4
°C in 4% paraformaldehyde, rinsedwith PBS, soaked in a PBS 30% sucrose
solution and embedded in either OCT or agarose for sectioning in a Leica
Cryostat (CM 1900) or a Vibratome (VT1000). The sections were
blocked at room temperature for at least 1 h in 1% BSA (in PBS with
0.1% Triton X-100) before overnight incubationwith primary antibodies
at 4 °C. The sectionswere then incubated for 1.5 h at room temperature
with Alexa-conjugated goat secondary IgG antibodies (Life Technolo-
gies) and 0.1 ng/μl DAPI (Sigma). Images were captured on a Leica SP5
confocal microscope using a 40× oil-immersion objective and proc-
essed using a Fiji software. MECP2 intensity was quantiﬁed using the
Fiji software as the following: each side of the neural tube (MECP2 EP
and control) was selected as a region of interest (ROI) and the total in-
tensity of all pixels for each ROI was calculated and compared.
Statistical analysis
Quantitative data were expressed as mean and standard error (s.e.).
Signiﬁcant differences between groups were tested by Student's t-test.
Results
Chicken MECP2 is expressed ubiquitously in the developing spinal cord
MECP2 is present in all vertebrates and is highly conserved among
mammals, while divergence between mammalian and amphibian or
ﬁsh MeCP2 more extensive. However, the alignment of chicken
MECP2 with mouse and humanMECP2 shows that the protein is highly
conserved throughout species as diverse as humans and chickens. Al-
though cMECP2 mRNA and protein are only partially annotated, a
large part of the sequence is highly similar to humanMECP2. Particular-
ly striking is the 96.8% sequence identity in a 125-amino-acid region.
Signiﬁcantly, the conserved region includes themethyl-CpGbindingdo-
main (MBD) (Weitzel et al., 1997) (Fig. 1a). The high degree of conser-
vation compares well with the characterization of the MBD as an
essential element for binding of MECP2 to heterochromatin as well as
unmethylated four-way DNA junctions (Galvão and Thomas, 2005;
Nan et al., 1996). Hence, we wondered whether cMECP2 (previously
known as ARBP) is expressed in the chicken embryo across different de-
velopmental stages. RT-PCR analysis of HH10, 20, 23 and 26 revealed
that cMECP2 is indeed expressed in chick embryo (Fig. 1b) with greater
expression seen at the HH20 stage. Since transcript presence does not
always correlate with protein levels, we checked cMECP2 protein by
western blot. Fig. 1c shows that cMECP2 is expressed at every tested de-
velopmental stage. Although in HH10 chick embryos the neural tube is
formed mainly by the ventricular zone (VZ)—an epithelium composed
entirely of mitotically active, multipotent neural precursor cells—from
HH14 to 15 some of these neuroblasts exit the cell cycle andmigrate lat-
erally from the ventricular zone to the mantle zone (MZ), which is
formed exclusively by post-mitotic, differentiating neurons and glia
(Fig. 1d). Therefore, we wondered whether the MECP2 expression was
restricted to the differentiating neurons or was global. To address this
issue, we collected brachial sections of HH25 embryos and stained
Fig. 1. cMECP2 is ubiquitously expressed in the developing spinal cord. (a) Protein sequences of chicken (Accession no. CAA74577), human (NP_001104262) andmouse (NP_001075448)
MECP2were aligned. The region inside the black box shows that the human sequence and the chicken sequence share 96.8% identity.MBD (yellow) and TRD (red) domains are highlight-
ed. (b) RT-PCR onHH10, 20, 23 and 26 neural tube RNA extracts. Minus reverse transcriptase samples (−RT) are shown on the right. (c) Immunoblot onHH10, 20, 23 and 26 neural tubes.
(d) Scheme showing the neural tube organization at HH10 and 25. (e) The cMeCP2 fragment is partly conserved with the human peptide recognized by the antibody. (f) HH25 embryos
were dissected and brachial sections were stained for MECP2 (red) and DAPI (blue).
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Fig. 1e. The chickenMECP2 partial annotated region shows high homol-
ogywith the aminoacidic region of themammalianMECP2 counterpart,
thus, expecting that the antibody recognizes chickenMECP2 speciﬁcally
(Weitzel et al., 1997). The results illustrate high expression of cMECP2
in ventral and in more dorsal ventricular cells as well as in mantle
cells (Fig. 1f, top panel). Thus, MECP2 is present both in differentiated
neurons and in neural progenitors.Moreover, we found that cMECP2 lo-
calizes in the nucleus, as staining of MECP2 overlaps with DAPI (Fig. 1f,
bottom panel).
MECP2 overexpression reduces neuroblast proliferation
To investigate the role of a protein, lack and gain-of function studies
are needed. The pCIG plasmid has been used in many gain-of-function
studies to obtain new insights on genes function relevant for develop-
ment, such as hJag1 (Neves et al., 2011), Wnt (Megason and
McMahon, 2002), EZH2 (Akizu et al., 2010) and FGF (Martínez-
Morales et al., 2011) among others, whose expression reached high
levels when electroporated in ovo. Although different shRNA of the
cMECP2 annotated region have been electroporated in chicken embryo,
none of them worked (data not shown).Humans and mice have two protein isoforms produced by the alter-
native splicing of the MECP2/MECP2 gene with the MECP2E1 and E2
isoforms, differing only in their N-terminal sequences (Kriaucionis and
Bird, 2004). It is known that MECP2E1-speciﬁc mutations alone are
able to cause RTT (Gianakopoulos et al., 2012) and MECP2E1 displays
10 times more expression than E2 (Dragich et al., 2007). In addition, a
recent study reported the differential distribution of MeCP2E1 within
various brain regions in mice (Zachariah et al., 2012). With the aim to
investigate the presence of different MECP2 isoforms in chicken we
used a RT-PCR approach. Our exon-speciﬁc RT-PCR experiments based
on the protein alignment between human and chicken and designed
to amplify the sequence between Exons 1 and 3, failed to detect a sec-
ond cMECP2 transcript (data not shown).
In order to analyze the effects of increasedMECP2 dosage on the de-
veloping neural tube, we cloned MECP2_E1 full-length into a pCIG vec-
tor under the control of a CMV promoter. The additional expression of a
nuclear-localized GFP from an internal ribosome entry site (IRES) en-
abled easy identiﬁcation of transfected cells. In ovo injection of MECP2
expression plasmid intoHH10 embryos and subsequent electroporation
led to efﬁcient and unilateral expression of this protein in the neural
tube as it is shown in Fig. 2a, where the GFP channel colocalizes with
theMECP2 red channel. Noteworthy, the pattern of nuclear localization
Fig. 2. Neuroblast proliferation is reduced uponMECP2 overexpression. HH10 embryos were electroporatedwith MECP2 or the empty vector in a bicistronic plasmid containing EGFP. All
sections were taken from the brachial region. (a) MECP2 immunostaining (red) of embryos at 72 h PE. The graph shows MECP2 area intensity of MECP2 EP neural tubes relative to the
empty vector (pCIG). Intensities were quantiﬁed by a Fiji software. Data shows mean of n = 3 sections (from 3 different embryos). Error bars indicate s.e. *p b 0.05. (b) BrdU immuno-
staining (red) of 72 h PE embryos. Themagniﬁed red boxes show themost affected regions. The graph shows the number of BrdU positive cells found inMECP2 EP neural tubes relative to
pCIG. Data show the mean of n= 9 sections (from three embryos). Error bars indicate s.e. ***p b 0.001. (c) H3S10p immunostaining (blue). The magniﬁed red boxes show the most af-
fected regions. The graph shows thenumber ofH3S10p positive cells found inMECP2 EPneural tubes relative to pCIG. Data for pCIG show themean ofn=8sections (from three embryos),
for MECP2 n= 12 sections (from two embryos). Error bars indicate s.e. **p b 0.01.
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and the intensity of MECP2 signal is increased. Quantiﬁcation of
MECP2 intensity in electroporated (EP) neural tube compared with
pCIG EP reveals an average of 45-foldmoreMECP2 in the electroporated
region (Fig. 2a, graph). Although at 24 hours post-electroporation (PE)
the neural tubes did not show any evidence of altered phenotypes, at48 (data not shown) and 72 hours PE the thickness and the structure
of electroporated neural tubes were highly affected, compared to the
non-electroporated side or to the empty vector. The most striking fea-
ture associated with the overexpression of MECP2 was the vastly re-
duced area occupied by the MZ, whose strong phenotype is
appreciated in Figs. 2b, c, 3a, b and c.
Fig. 3.MECP2 overexpression provokes ectopic localization of differentiated neurons. a Tuj1 immunostaining (gray, upper panel) of embryos at 72 h PE. GFP is shown in the lower panel.
For MECP2 EP, two embryos are shown. The magniﬁed red box shows ectopically differentiating neurons. b HuC/D immunostaining (gray, upper panel). For MECP2 EP, two embryos are
shown. c N-cadherin immunostaining (gray, upper panel). The magniﬁed red box shows disruption of the N-cadherin pattern by MECP2.
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profoundly alters neural tube organization, we examined the prolifera-
tion rate of electroporated neural tubes. We took embryos at 72 h PE
and processed them for bromodeoxyuridine (BrdU) staining, showing
that MECP2 overexpression leads to an overall decrease in the number
of proliferating BrdU positive cells (Fig. 2b). Noteworthy, the most af-
fected part corresponds with higher levels of GFP (compare zoomsquares of pCIG EP and MECP2 EP panels in Fig. 2b). In addition, in EP
pCIG, GFP-labeled cells accumulated at the mantle zone due to the nor-
mal migration accompanying neuronal differentiation, while in EP
MECP2 electroporated cells gatheredmainly in theVZ, thereforemaking
not possible to assess colocalization between GFP and BrdU. In order to
quantify BrdU incorporation, BrdU labeled cells in control (pCIG) and
MECP2 EP neural tubes were normalized with the total number of
54 P. Petazzi et al. / Neurobiology of Disease 67 (2014) 49–56BrdU-positive cells in the respective non-EP side (graph of Fig. 2b). Re-
sults clearly indicate a reduction around 20% in BrdU levels as a result of
MECP2 overexpression. We then wondered whether MECP2 overex-
pression affected also the levels of H3S10 phosphorylation, a histone
mark that correlates with mitotically active cell populations. The
H3S10p marker highlighted a mislocalization of actively dividing cells
that normally reside close to the lumen. Again, higher levels of GFP co-
incide with disruption of H3S10p pattern (compare zoom square of
pCIG EP and MECP2 EP panels in Fig. 2c). Quantiﬁcation of anti-
H3S10p immunostaining also showed that MECP2-electroporated neu-
ral tubes has a 20% decrease in the amount of mitotic cells than did the
control neural tubes (Fig. 2c, graph). Collectively, these data emphasize
the importance of proper spatial–temporal MECP2 expression for en-
suring correct proliferation of progenitor cells residing in the ventricular
zone of the neural tube.
MECP2 overexpression induces ectopic localization of differentiated neurons
Given that a role for MECP2 in promoting neuronal differentiation of
neural precursor cells has been proposed (Stancheva et al., 2003;
Tsujimura et al., 2009), wewonderedwhether the reduced proliferation
of neural progenitor cells that we observed stemmed from premature
induction of neurogenesis. To investigate this possibility, we took
MECP2-electroporated neural tubes at 72 h PE, and then stained them
with neural β-tubulin III (Tuj1), which is one of the earliest markers of
neuronal commitment in primitive neuroepithelium. Fig. 3a show that
MECP2 overexpression provokes a clear decrease in the amounts of dif-
ferentiated neuronal population located at the mantle zone (compare
zoom squares of pCIG control and MECP2 EP panels). Additionally, the
same images of Tuj1 staining also show an ectopic localization of differ-
entiated neurons in theMECP2-electroporated neural tubes. To conﬁrm
the phenotype caused by MECP2 overexpression, we immunostained
with another marker, HuC/D, an RNA-binding protein speciﬁc to neuro-
nal lineage. Again, when comparing MECP2 EP neural tubes with con-
trols, depletion of differentiated cells is observed in MZ of MECP2 EP
neural tubes (Fig. 3b, pCIG and MECP2 panels). This phenotype un-
equivocally shows an aberrant differentiation pattern for cells overex-
pressing MECP2, as it can be inferred by the presence of both GFP and
Tuj1 in ectopically differentiated cells. Due to the non-nuclear localiza-
tion of Tuj1 and HuC/D it has not been possible to quantify labeled
cells of these markers. However, quantiﬁcation of such qualitative
markerswas not necessary given that the difference in the level of stain-
ing of the mantle zone was striking, as well as it was the presence of
Tuj1-stained cells in the VZ, which is normally populated by proliferat-
ing cells.
Since Tuj1 stainingwas found in the ventricular zone, we decided to
check for neuroepithelial polarity markers, such as the cadherin family
of proteins. In particular, the pattern of N-cadherin (Cdh2), a transmem-
brane protein that mediates homophilic adhesion at the cell junctions,
was analyzed by immunostaining in the MECP2-electroporated neural
tubes (at 72 h PE). The results clearly demonstrate that MECP2 overex-
pression disrupts the N-cadherin expression pattern along the lamina of
the neural tube (Fig. 3c, compare zoomsquares of control andMECP2 EP
panels). This indicates that an increase in MECP2 dosage leads to a de-
crease in neuroepithelial polarity markers. These results suggest that,
in addition to exiting the cell cycle and suffering from compromised po-
larity, MECP2-overexpressing neural precursor cells do not reach termi-
nal differentiation, as can be inferred by reduced number of
differentiating neurons in the MZ (Figs. 3a, c MECP2 panel).
MECP2 overexpression induces cell death
The observations that at 72 h PE the number of Tuj1 labeled cells in
MECP2-electroporated neural tubes is vastly reduced, led us to analyze
the rate of apoptosis before the onset of the altered phenotype. To this
end, we determined the cellular levels of active Caspase-3 and −8,two well-known serine proteases that are activated during the early-
intermediate stages of apoptosis (reviewed in Parrish et al., 2013).
Caspase-8 is classiﬁed as an initiator caspase and it is one of the earliest
signals in the cascade, while Caspase-3 act downstream and can be
cleaved, and therefore activated, by Caspase-8. Control pCIG EP neural
tubes show very low levels of Caspase-3 and−8 labeled cells as expect-
ed (Figs. 4a and b pCIG EP panel, graph 4c and 4d). However, the num-
ber of Caspase-3 and Caspase-8 labeled cells in MECP2 EP compared
with pCIG EP neural tubes is signiﬁcantly higher both at 24 and 48 h
PE (Figs. 4a and b MECP2 EP panel, graph 4c and 4d). To conﬁrm these
data we quantiﬁed cells undergoing cell death by counting Dapi-
positive nuclei showing the characteristic condensed morphology.
Fig. 4e shows an increase of pyknotic cells in MECP2 EP, both at 24
and 48 h PE compared with pCIG EP neural tubes. These results clearly
indicate the presence of apoptotic cells upon MECP2 electroporation
and can explain the aberrant phenotype.
Discussion
To analyze the role of MECP2 in neurogenesis we have used a chick-
en model, however, we ﬁrst checked whether our model was suitable
for this purpose. First, expression of both cMECP2 transcript and protein
has been detected in a wide window of developmental stages. Then, we
have found that chickenMECP2 is functionally analogous to itsmamma-
lian counterpart since its nuclear localization and the conservation of
the region encompassing the methyl-CpG binding domain between
human and chicken.
Our data also indicate that MECP2 overexpression causes
neuroblasts to slow down proliferation, and that most of these
neuroblasts die before they can reach terminal differentiation (Fig. 4f).
Ectopic localization of differentiated neurons and reduced levels of po-
larity markers indicate that overexpression of MECP2 alone does not
control the changes in polarity and migration that accompany
neurogenesis. Neural cells die as a consequence of MECP2 overexpres-
sion, probably because they lack the additional spatial–temporal signals
necessary for proper progression of neurogenesis. These results are in
line with the lack of function studies from other models (Stancheva
et al., 2003), indicating that the consequences ofMECP2 overexpression
do not represent toxic effects but speciﬁc ones.
Tsujimura et al. (2009) showed thatMeCP2 overexpression in neural
precursor cells (NPCs) promotes neuronal differentiation in adult mice.
This work was based on the injection of embryo-derived NPCs in the
brain or spinal cord of adult mice. We provided a more reliable study
in which MECP2 ectopic expression has been induced in the chick neu-
ral tubewithout the need to deliver exogenous cells to the embryos. Our
results are consistent with previous studies, which reported abnormally
high levels of cell death in different in vitro systems overexpressing
MECP2, relative to wild-type cells (Bracaglia et al., 2009; Dastidar
et al., 2012). Bracaglia et al. also reported that this pro-apoptotic effect
disappearswhen theRett syndrome-associatedMECP2-R106Wmutant,
which is unable to bind to methylated DNA, is expressed—thereby im-
plying that the MBD domain is essential for MECP2-induced apoptosis.
It is remarkable that Xenopus laevisMeCP2was shown to regulate the
number of neural precursor cells in the differentiating neuroectoderm of
early Xenopus embryos (Stancheva et al., 2003). In the absence of MeCP2
protein, the expression of Xenopus Hairy2a (a member of the Hes family
of proteins, which are regulated by the Notch/Delta signaling pathway)
was enhanced in embryos, which resulted in a lower number of differen-
tiated neurons. Our results, together with the aforementioned study,
highlight the importance of MECP2 dosage, as both knock-out and over-
expression of this protein results in a reduced number of differentiated
neurons. In our case, reduction in total number of cells is not due only
to apoptosis but in addition there is a proliferation problem.
Interestingly, our phenotype resembles the one produced by the ge-
netic ablation of Notch1 (de la Pompa et al., 1997). Loss of Notch signal-
ing results in premature onset of neurogenesis by neuroepithelial cells
Fig. 4.MECP2 overexpression induces cell death. (a–b) HH10 embryos were electroporated with MECP2 or empty vector. Embryonic sections (at 24 and 48 h PE) from brachial region were im-
munostained for Caspase 8 (a) (gray, lower panel) and Caspase 3 (b) (gray, lower panel). The red boxes in theMECP2 EP highlight the Caspase-positive spots. c–d The graphs show the number of
Caspase 8 (c) and Caspase 3 (d) positive cells in MECP2 EP neural tubes relative to pCIG EP at 24 and 48 h PE (pCIG 24 and 48 h n= 12 sections from 6 embryos; MECP2 24 h n= 21 from 10
embryos; MECP2 48 h n = 13 from 6 embryos). Error bars indicate s.e. *p b 0.05; **p b 0.01; ***p b 0.001. (e) Quantiﬁcation of cells showing pyknotic features in neural tubes at 24 and 48 h
PE (pCIG 24 and 48 h n= 12 sections from 6 embryos; MECP2 24 h n= 21 from 10 embryos; MECP2 48 h n= 13 from 6 embryos). Error bars indicate s.e. **p b 0.01; ***p b 0.001. (f) Model
for MECP2 overexpression consequences in neural tube.
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cells do not complete differentiation but instead are eliminated by apo-
ptosis, resulting in a reduced number of neurons in the adult cerebellum
(Lütolf et al., 2002).
The molecular mechanism responsible of this phenotype can be ex-
plained by the relevant interactions betweenMECP2 and other proteins.
For example, the MECP2-associated kinase HIPK2 has been shown to
regulate cell growth and apoptosis, both in vivo and in vitro (Bracaglia
et al., 2009). In addition, MECP2 interacts with many co-factors crucial
for both proliferation and differentiation, such as HDAC2 (MacDonald
et al., 2010) and NCOR/SMRT (Ebert et al., 2013).
This is the ﬁrst study that investigates the consequences of MECP2
gain-of-function in the nervous system of an in-vivo model in the
early stages of development. In particular, we introduce the novel idea
that high expression of MECP2 in mitotic cells leads to anti-
proliferative and apoptotic effects. Several cases of increased MECP2
copy number have been reported in male patients with progressive
neurodevelopmental delay phenotype (Friez et al., 2006; Lugtenberg
et al., 2006; Meins et al., 2005; Van Esch et al., 2005). Interestingly, a
male patient with triplication of the MECP2 locus was described to
have an even worse early-onset neurological phenotype at 3 months
of age (del Gaudio et al., 2006), suggesting that the severity of an
MECP2 overexpression phenotype is proportional to the copy number
increase. In order to reinforce this hypothesis, researchers have studied
a mouse model expressing seven times the wild-type levels of MeCP2protein, reporting that it died by 3 weeks of age (Collins et al., 2004). Al-
though the levels of MECP2 expression induced in the chicken neural
tubes that we have described in the present study are not fully repre-
sentative of the physiological situation in patients with MECP2-related
disorders, our results are in line with lack and gain of function studies
that elucidate the importance of correct gene dosage in neuronal devel-
opment and disorders.
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